{"podcast":{"title":"A Health Podyssey","slug":"a-health-podyssey-1366621","podcast_index_feed_id":1366621,"rss_url":"https://feeds.transistor.fm/a-health-podyssey","website_url":"https://www.healthaffairs.org/podcasts","image_url":"https://img.transistorcdn.com/CA0GVoNR-7-repgsjaV9h8eCWrF2C-P6WydGA5djdoE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE0ODU4LzE2MDE0/MDI1NzEtYXJ0d29y/ay5qcGc.jpg","author":"Health Affairs","episode_count":300,"summary":"Each week, Health Affairs' Rob Lott brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry. A Health Podyssey goes beyond the pages of the health policy journal Health Affairs to tell stories behind the research and share policy implications. Learn how academics and economists frame their research questions and journey to the intersection of health, health care, and policy. Health policy nerds rejoice! This podcast is for you.","last_synced_at":"2026-06-09T14:18:31.789919+00:00","page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621"},"episode":{"title":"How Drug Price Negotiation Is Reshaping Clinical Trial Pipelines","slug":"how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines","published_at":"2026-02-24T05:00:00+00:00","page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621/how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines","show_page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621","url":"https://share.transistor.fm/s/13d8613e","audio_url":"https://media.transistor.fm/13d8613e/567db246.mp3","summary":"Health Affairs ' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs . Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support , we can continue to keep our digital publication Forefront and podcast for everyone.","meta_description":"Health Affairs ' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials af…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1232,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/a-health-podyssey-1366621/how-drug-price-negotiation-is-reshaping-clinical-trial-pipelines.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}